HEMATOLOGIC MALIGNANCIES
Clinical trials for HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood filter could be key to saving High-Risk transplant patients
Disease control CompletedThis study looked back at 50 patients with blood cancers or disorders who received a stem cell transplant from a partially matched family donor. Before the transplant, some patients received a special blood-filtering treatment to remove antibodies that could cause the body to rej…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Sponsor: Ting YANG • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for blood cancer patients lacking perfect donor matches
Disease control CompletedThis study tested a less intense bone marrow transplant for people with serious blood cancers who did not have a perfectly matched donor available. It used donors who were not close relatives or were only a partial match, combined with specific immune-suppressing drugs after the …
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Psoriasis drug shows promise in preventing deadly transplant complication
Disease control CompletedThis study tested whether tildrakizumab, a drug approved for psoriasis, could prevent graft-versus-host disease (GVHD) in patients receiving stem cell transplants for blood cancers. The trial involved 51 adults who received the drug alongside their transplant to see if it could r…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Early trial tests novel combo for aggressive lymphomas that resist treatment
Disease control CompletedThis early-stage study tested the safety and effectiveness of a new three-drug combination (VVIP) for adults with aggressive non-Hodgkin lymphomas that had returned or not responded to prior treatments. The goal was to find the highest safe dose and see if the treatment could mak…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Did COVID change a deadly fungus? study looks at cancer patients
Knowledge-focused CompletedThis study looked back at medical records to understand how the COVID-19 pandemic affected a serious fungal infection called mucormycosis in people with blood cancers. Researchers compared 60 patients from before and during the pandemic to see if infection rates, diagnosis method…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC
-
Study aims to give voice to older blood cancer patients in critical care decisions
Knowledge-focused CompletedThis small pilot study tested whether having advance care planning conversations with a trained facilitator during a hospital stay could help older adults with blood cancers. The goal was to see if these conversations helped patients think about and document their preferences for…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:23 UTC